Viewing Study NCT00993668


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2026-01-05 @ 3:28 AM
Study NCT ID: NCT00993668
Status: COMPLETED
Last Update Posted: 2018-08-01
First Post: 2009-10-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines
Sponsor: UCB Pharma
Organization: